• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于分层评估肺耐多药结核病风险的临床预测规则。

Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.

机构信息

Institute of Tropical Medicine Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.

出版信息

PLoS One. 2010 Aug 11;5(8):e12082. doi: 10.1371/journal.pone.0012082.

DOI:10.1371/journal.pone.0012082
PMID:20711459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2920322/
Abstract

BACKGROUND

Multidrug-resistant tuberculosis (MDR-TB), resistance to at least isoniazid and rifampin, is a worldwide problem.

OBJECTIVE

To develop a clinical prediction rule to stratify risk for MDR-TB among patients with pulmonary tuberculosis.

METHODS

Derivation and internal validation of the rule among adult patients prospectively recruited from 37 health centers (Perú), either a) presenting with a positive acid-fast bacillus smear, or b) had failed therapy or had a relapse within the first 12 months.

RESULTS

Among 964 patients, 82 had MDR-TB (prevalence, 8.5%). Variables included were MDR-TB contact within the family, previous tuberculosis, cavitary radiologic pattern, and abnormal lung exam. The area under the receiver-operating curve (AUROC) was 0.76. Selecting a cut-off score of one or greater resulted in a sensitivity of 72.6%, specificity of 62.8%, likelihood ratio (LR) positive of 1.95, and LR negative of 0.44. Similarly, selecting a cut-off score of two or greater resulted in a sensitivity of 60.8%, specificity of 87.5%, LR positive of 4.85, and LR negative of 0.45. Finally, selecting a cut-off score of three or greater resulted in a sensitivity of 45.1%, specificity of 95.3%, LR positive of 9.56, and LR negative of 0.58.

CONCLUSION

A simple clinical prediction rule at presentation can stratify risk for MDR-TB. If further validated, the rule could be used for management decisions in resource-limited areas.

摘要

背景

耐多药结核病(MDR-TB),即至少对异烟肼和利福平耐药,是一个全球性问题。

目的

为耐多药结核病患者建立一种临床预测规则,以分层风险。

方法

从 37 个医疗中心(秘鲁)前瞻性招募的成年患者中得出并内部验证该规则,纳入标准为:a)痰抗酸杆菌涂片阳性,或 b)治疗失败或在最初 12 个月内复发。

结果

在 964 名患者中,有 82 名患有 MDR-TB(患病率为 8.5%)。纳入的变量包括家庭内 MDR-TB 接触史、既往结核病、空洞性放射学模式和异常肺部检查。受试者工作特征曲线下面积(AUROC)为 0.76。选择得分≥1 作为截断值,灵敏度为 72.6%,特异度为 62.8%,阳性似然比(LR+)为 1.95,阴性似然比(LR-)为 0.44。同样,选择得分≥2 作为截断值,灵敏度为 60.8%,特异度为 87.5%,LR+为 4.85,LR-为 0.45。最后,选择得分≥3 作为截断值,灵敏度为 45.1%,特异度为 95.3%,LR+为 9.56,LR-为 0.58。

结论

一种简单的临床预测规则可在发病时对 MDR-TB 进行分层。如果进一步验证,该规则可用于资源有限地区的管理决策。

相似文献

1
Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.用于分层评估肺耐多药结核病风险的临床预测规则。
PLoS One. 2010 Aug 11;5(8):e12082. doi: 10.1371/journal.pone.0012082.
2
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.肺切除术联合基于异烟肼和利福平的药物治疗用于耐多药和广泛耐药结核病患者。
Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.
3
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.《2006年抗结核药物国际共识指南:肺结核、肺外结核及特殊情况结核病的管理》
J Assoc Physicians India. 2006 Mar;54:219-34.
4
Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴涂片阴性疑似肺结核患者中结核病、耐多药结核病及相关危险因素的流行情况。
BMC Infect Dis. 2019 Jul 19;19(1):641. doi: 10.1186/s12879-019-4241-7.
5
Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.基因分型MTBDRplus检测法在喀麦隆诊断耐多药结核病中的诊断准确性及实用性?一项横断面研究。
BMC Infect Dis. 2017 May 31;17(1):379. doi: 10.1186/s12879-017-2489-3.
6
Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid.BD MAX 耐多药结核病检测试剂盒检测结核分枝杆菌复合群及利福平、异烟肼耐药相关突变的准确性:多中心研究
Clin Infect Dis. 2020 Aug 22;71(5):1161-1167. doi: 10.1093/cid/ciz932.
7
Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.英国伦敦东部边界地区既往治疗与耐药结核病的相关性。
Int J Infect Dis. 2010 Aug;14(8):e717-22. doi: 10.1016/j.ijid.2010.02.2247. Epub 2010 Jun 12.
8
Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients.耐多药肺结核患者中 II 型肺结核患者的患病率。
Indian J Med Res. 2011 Mar;133(3):312-5.
9
Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.埃塞俄比亚西南部地区耐多药结核病的预测因素:一项病例对照研究。
Ann Clin Microbiol Antimicrob. 2018 Jul 3;17(1):30. doi: 10.1186/s12941-018-0283-8.
10
The management of tuberculosis: epidemiology, resistance and monitoring.结核病的管理:流行病学、耐药性与监测
Dan Med Bull. 2010 Nov;57(11):B4213.

引用本文的文献

1
Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.为印度尼西亚肺结核病耐利福平筛查开发并实施 CUHAS-ROBUST 应用软件。
PLoS One. 2021 Mar 25;16(3):e0249243. doi: 10.1371/journal.pone.0249243. eCollection 2021.
2
Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of Veterans.退伍军人国家队列中艰难梭菌感染复发预测规则的推导和验证。
Pharmacotherapy. 2018 Mar;38(3):349-356. doi: 10.1002/phar.2088. Epub 2018 Feb 22.
3
Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil.巴西五个参考中心疑似耐多药结核病患者的治疗结果。
BMC Infect Dis. 2017 Aug 15;17(1):571. doi: 10.1186/s12879-017-2669-1.
4
Serious fungal infections in Peru.秘鲁的严重真菌感染。
Eur J Clin Microbiol Infect Dis. 2017 Jun;36(6):943-948. doi: 10.1007/s10096-017-2924-9. Epub 2017 Feb 10.
5
Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.在津巴布韦哈拉雷,使用Xpert(®)MTB/RIF检测利福平耐药性及开始治疗的时间。
Int J Tuberc Lung Dis. 2016 Jul;20(7):882-9. doi: 10.5588/ijtld.15.0696.
6
Rationing tests for drug-resistant tuberculosis - who are we prepared to miss?对抗耐药结核病检测进行配给——我们准备遗漏哪些人?
BMC Med. 2016 Mar 23;14:30. doi: 10.1186/s12916-016-0576-8.
7
Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil.巴西阿雷格里港第二次全国抗结核药物耐药性调查中纳入对象的耐多药结核病。
J Bras Pneumol. 2014 Mar-Apr;40(2):155-63. doi: 10.1590/s1806-37132014000200009.
8
A predictive scoring instrument for tuberculosis lost to follow-up outcome.用于结核病失访结局预测的评分工具。
Respir Res. 2012 Sep 2;13(1):75. doi: 10.1186/1465-9921-13-75.
9
Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatment.新结核病例中多种药物耐药的自我报告风险:对药物敏感性筛查和治疗的影响。
PLoS One. 2011;6(10):e25861. doi: 10.1371/journal.pone.0025861. Epub 2011 Oct 14.
10
GeneXpert--a game-changer for tuberculosis control?GeneXpert——结核病控制的游戏规则改变者?
PLoS Med. 2011 Jul;8(7):e1001064. doi: 10.1371/journal.pmed.1001064. Epub 2011 Jul 26.

本文引用的文献

1
Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam.验证 GenoType MTBDRplus 检测试剂盒在越南南部诊断耐多药结核病的效能。
BMC Infect Dis. 2010 Jun 3;10:149. doi: 10.1186/1471-2334-10-149.
2
Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic.快速鉴定中非共和国班吉治疗失败或复发患者中的耐多药结核分枝杆菌分离株。
Int J Tuberc Lung Dis. 2010 Jun;14(6):782-5.
3
Drug-susceptibility testing in TB: current status and future prospects.结核分枝杆菌药物敏感性检测:现状与展望。
Expert Rev Respir Med. 2009 Oct;3(5):497-510. doi: 10.1586/ers.09.45.
4
Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.使用分子线探针杂交技术快速筛查耐多药结核病在乌干达是可行的。
BMC Infect Dis. 2010 Feb 26;10:41. doi: 10.1186/1471-2334-10-41.
5
An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia.俄罗斯采用液体培养和分子方法快速诊断结核病和耐多药结核病的综合方法。
PLoS One. 2009 Sep 23;4(9):e7129. doi: 10.1371/journal.pone.0007129.
6
Predictors of extensively drug-resistant pulmonary tuberculosis.广泛耐药性肺结核的预测因素
Ann Intern Med. 2009 Jun 2;150(11):766-75. doi: 10.7326/0003-4819-150-11-200906020-00004.
7
Thai drug-resistant tuberculosis predictive scores.泰国耐药结核病预测评分。
Singapore Med J. 2009 Apr;50(4):378-84.
8
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.2002 - 2007年抗结核药物耐药性流行病学:全球抗结核药物耐药性监测项目的最新分析
Lancet. 2009 May 30;373(9678):1861-73. doi: 10.1016/S0140-6736(09)60331-7. Epub 2009 Apr 15.
9
Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis.
Infect Control Hosp Epidemiol. 2008 Oct;29(10):927-32. doi: 10.1086/590667.
10
Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study.利福平耐药性的快速分子检测有助于多药耐药结核病的早期诊断和治疗:病例对照研究
PLoS One. 2008 Sep 9;3(9):e3173. doi: 10.1371/journal.pone.0003173.